Accuray Incorporated (Nasdaq: ARAY), based in Sunnyvale, Calif., is the premier radiation oncology company. Accuray develops, manufactures and sells personalized, best-in-class treatment solutions that revolve around the patient. Accuray’s game-changing technologies – the CyberKnife System and TomoTherapy Systems – set the standard of care with the aim of helping patients live longer, better lives. To date, more than 200,000 patients worldwide have been treated using the company’s technologies and more than 550 systems have been installed in leading hospitals around the world. On November 4, 2008, the Company completed the acquisition of Chengdu Twin Peak Accelerator Technology Inc.
The TomoTherapy treatment systems contain a linear accelerator, which is a device that generates external beam radiation that is used both to capture images that accurately depict the size, shape, and density of the tumor, and to deliver therapeutic radiation to ed targets in a helical, or spiral, delivery pattern 360 degrees around the body.

Accuray Incorporated （納斯達克股票代碼：ARAY）專業(yè)從事先進的放射治療解決方案的開發(fā)和銷售，其解決方案可用于治療各種從最普通到最復雜的癌癥。Accuray的Cyberknife和TomoTherapy平臺采用滑環(huán)機架，將集成CT成像與適形放射治療相結合，快速精確地提供尖端的放射治療，同時降低周圍健康組識受輻射的程度。Accuray和北美、歐洲、中東以及亞太地區(qū)的醫(yī)院和癌癥治療中心有著密切的合作關系。在2008年11月4日，宣布全資收購成都雙峰加速器技術有限公司。
TomoTherapy的Hi-Art全方位治療系統(tǒng)裝配了醫(yī)用直線加速器。 該加速器可以產生外部的輻射束，有助于生成對腫瘤大小，形狀，位置及密度準確定位的圖像，同時直線加速器能夠對身體需要治療部位發(fā)射螺旋狀治療射線，以便對患處進行360度全方位治療。
自從Accuray收購中國這家高科技民營企業(yè)后器，改變直線加速管供貨來源單一的局面，而直線加速管又是公司生產的放療設備Hi?Art的最重要的部件，同時，這項并購還能提高公司在支線加速器設計和制造上的競爭能力，有助于改善設備的穩(wěn)定性，并有助于提升利潤空間。
Welcome to visit our website http://www.accuray.com/ for more information.
請訪問公司網站，了解更多信息。